| Name | Title | Contact Details |
|---|
DistroKid is a digital music distribution service based in the United States, founded in 2013 by Philip Kaplan. It emerged from a social media platform for musicians called Fandalism. DistroKid specializes in helping independent artists and labels distribute their music to major online retailers, including Spotify, Apple Music, Amazon Music, and YouTube Music. The company offers a range of services to support musicians, including music distribution, monetization of sales and streams, and metadata customization. DistroKid also provides storage solutions for music files and additional features like customized YouTube URLs and Digital Object Identifiers (DOIs). With a competitive pricing model, artists can upload unlimited songs and albums for an annual fee, while retaining 100% of their earnings. DistroKid has been utilized by various notable artists, showcasing its effectiveness in the DIY music distribution space.
Athol Savings Bank is a mutual savings bank based in Athol, Massachusetts. Our goal is to be the financial foundation in our community; working harder, reaching higher, and delivering strength, stability, and security to our customers. As we move forward, Athol Savings Bank is committed to being "A Solutions Bank" for our customers and the communities we serve. Member FDIC. Equal Housing Lender. Member DIF.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Coast2Coast HR, LLC specializes in helping organizations with leadership development, leader coaching, group training, investigations, policy review, handbooks, recruitment services, and working with HR teams to better align them to business expectations. We also work directly with HR departments to help them meet their expectations. Our senior-level team members assess the current state of the department, make recommendations to address concerns, and take action on the approved plan. Once the department meets its goals, we can recruit a replacement if required, and the contract will be complete. Our estimated timelines are 6 to 12 months.